VXCO-102

N/A

Report date: 2026/05/04 20:01:27

Base Information

Drug NameVXCO-102
Drug Alias NameVXCO-102
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsEpstein-Barr Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe Vaccine Company
China Registration ClassN/A

Develop Information

Active CompaniesThe Vaccine Company
Inactive CompaniesN/A
Active IndicationsEpstein-Barr Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A